39 reports

  • ALLERGY RHINITIS DRUGS MARKET IN AMERICAS ($ MILLIONS)
  • ALLERGY RHINITIS DRUGS MARKET IN EMEA 2016-2021 ($ MILLIONS)

Immunotherapies is one of the most lucrative segments of the Global allergy rhinitis drugs market owing to the increased drug development in this segment.

  • Pharmaceutical
  • Respiratory Disease
  • World
  • GlaxoSmithKline plc
  • Sanofi S.A.
  • PROTEINS FOR ASTHMA AND ALLERGY - DRUG PROFILE
  • PROTEIN FOR ALLERGIC ASTHMA AND FOOD ALLERGY - DRUG PROFILE

The drug candidate targets the allergens (Derp ##) that can trigger allergies and asthma attacks directly.

  • Asthma
  • Respiratory Disease
  • United States
  • Company
  • AstraZeneca PLC
  • ALLERGEN FOR ALLERGIC RHINITIS, ALLERGIC RHINO-CONJUNCTIVITIS AND BIRCH POLLEN ALLERGY - DRUG PROFILE
  • Allergen for Allergic Rhinitis, Allergic Rhino-Conjunctivitis and Birch Pollen Allergy

The drug candidate is a human immunoglobulin monoclonal antibody targeting eotaxin-##.

  • Chronic Disease
  • Respiratory Disease
  • United States
  • Company
  • Product Initiative

Drug Allergy- The allergy from medicines, drugs is the most common form of allergy.

  • Respiratory Disease
  • World
  • Market Size
  • Merck & Co., Inc.
  • Stallergenes Greer plc
  • PROTEINS FOR ASTHMA AND ALLERGY - DRUG PROFILE
  • PROTEIN FOR ALLERGIC ASTHMA AND FOOD ALLERGY - DRUG PROFILE

The drug candidates target the allergens (Derp ##) that can trigger allergies and asthma attacks directly.

  • Asthma
  • Pharmaceutical
  • Research And Development
  • Respiratory Disease
  • AstraZeneca PLC

THE DRUG CANDIDATE IS A ## MER PEPTIDE ACTS BY TARGETING PROGRAMMED CELL DEATH ## LIGAND ## (PD-L##).

  • Blood Disease
  • Cell Therapy
  • Respiratory Disease
  • Therapy
  • Bristol-Myers Squibb Company
  • ALLERGEN FOR ALLERGIC RHINITIS, ALLERGIC RHINO-CONJUNCTIVITIS AND BIRCH POLLEN ALLERGY - DRUG PROFILE
  • Allergen for Allergic Rhinitis, Allergic Rhino-Conjunctivitis and Birch Pollen Allergy

The drug candidate activates allergen-specific T-helper type ## (Th##) cellular responses with the production of interferons by antigen presenting cells (APC), natural killer cells (NK), and T cells.

  • Allergy Drug
  • Ophthalmic Solution
  • Pharmaceutical
  • Respiratory Disease
  • Allergy Therapeutics plc
  • Official Title

ACUTE RESPIRATORY FAILURE THERAPEUTICS CLINICAL TRIALS, GLOBAL, ONGOING CLINICAL TRIALS BY PROMINENT DRUGS, 2018* PROMINENT DRUGS ACUTE RESPIRATORY FAILURE THERAPEUTICS CLINICAL TRIALS, GLOBAL, ONGOING CLINICAL TRIALS BY PROMINENT DRUGS, 2018* ACUTE RESPIRATORY FAILURE THE

  • Chronic Disease
  • Respiratory Disease
  • Therapy
  • World
  • Product Initiative
  • Nasal Polyps (Nasal Polyposis) - Drug Profiles

The drug candidate is in Phase II stage for peanut allergy, grass pollen allergy, chronic urticaria, and dermatitis globally.

  • Chronic Disease
  • Respiratory Disease
  • United States
  • Product Initiative
  • Regeneron Pharmaceuticals, Inc.

THE DRUG CANDIDATE IS A ## MER PEPTIDE ACTS BY TARGETING PROGRAMMED CELL DEATH ## LIGAND ## (PD-L##).

  • Blood Disease
  • Cell Therapy
  • Respiratory Disease
  • Therapy
  • Bristol-Myers Squibb Company

The LUTE / VERSE findings were presented at the annual meeting of the American Academy of Allergy, Asthma and Immunology (AAAAI) in San Diego, California, US.

  • Asthma
  • Medical Biotechnology
  • Respiratory Disease
  • United States
  • Product Initiative
  • ACT-774312 - DRUG PROFILE

One group was given ##mg of the drug twice a day for ## weeks and the other participants were assigned to a placebo group.

  • Asthma
  • Respiratory Disease
  • United States
  • World
  • Product Initiative

About ## percent of people who have food allergies are allergic to more than one food.

  • Chronic Disease
  • Respiratory Disease
  • United States
  • Product Initiative
  • Regeneron Pharmaceuticals, Inc.

The prominent features of this report are - ##.

  • OTC
  • Respiratory Disease
  • Therapy
  • World
  • Product Initiative

The molecules developed by Companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are ##, ##, ##, ## and ## respectively.

  • Medical Biotechnology
  • Pharmaceutical
  • Respiratory Disease
  • United States
  • Product Initiative

About ## percent of people who have food allergies are allergic to more than one food.

  • Monoclonal Antibody
  • Pharmaceutical
  • Respiratory Disease
  • Therapy
  • Regeneron Pharmaceuticals, Inc.
  • CLINICAL TRIAL PROFILE SNAPSHOTS

PROMINENT DRUGS RESPIRATORY FAILURE THERAPEUTICS CLINICAL TRIALS, GLOBAL, ONGOING CLINICAL TRIALS BY PROMINENT DRUGS, 2018* RESPIRATORY FAILURE THERAPEUTICS CLINICAL TRIALS, GLOBAL, ONGOING CLINICAL TRIALS BY PROMINENT DRUGS, 2018* RESPIRATORY FAILURE THERAPEUTICS CLINICAL

  • Chronic Disease
  • Respiratory Disease
  • Therapy
  • World
  • Product Initiative

One group was given ##mg of the drug twice a day for ## weeks and the other participants were assigned to a placebo group.

  • Asthma
  • Respiratory Disease
  • Therapy
  • World
  • Product Initiative
  • SMALL MOLECULES FOR SEASONAL ALLERGIC RHINITIS - DRUG PROFILE
  • Research and Development Brief

THE DRUG CANDIDATE IS A MUTANT DERIVATIVE BIRCH POLLEN ALLERGEN BET V ##.

  • Allergy Drug
  • Allergy Immunotherapy
  • Respiratory Disease
  • Therapy
  • Product Initiative
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

DRUG/ MOLECULE REFERS TO PRIMARY INTERVENTION ONLY. ##.

  • Clinical Trial
  • Molecular Diagnostics
  • Pharmaceutical
  • Respiratory Disease
  • World
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

DRUG/ MOLECULE REFERS TO PRIMARY INTERVENTION ONLY. ##.

  • Allergy Drug
  • Drug Development
  • Pharmaceutical
  • Respiratory Disease
  • World

One group was given ##mg of the drug twice a day for ## weeks and the other participants were assigned to a placebo group.

  • Pharmaceutical
  • Respiratory Disease
  • United Kingdom
  • World
  • Product Initiative
  • ALLERGEN FOR ALLERGIC RHINITIS AND RHINOCONJUNCTIVITIS - DRUG PROFILE
  • Allergen for Allergic Rhinitis and Allergic Rhino-Conjunctivitis

The molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I and Discovery stages are ##, ##, ##, ## and ## respectively.

  • Allergy Drug
  • Ophthalmic Solution
  • Pharmaceutical
  • Respiratory Disease
  • Allergy Therapeutics plc

EDEMA THERAPEUTICS CLINICAL TRIALS, GLOBAL, ONGOING CLINICAL TRIALS BY PROMINENT DRUGS, 2017* PROMINENT DRUGS EDEMA THERAPEUTICS CLINICAL TRIALS, GLOBAL, ONGOING CLINICAL TRIALS BY PROMINENT DRUGS, 2017* EDEMA THERAPEUTICS CLINICAL TRIALS, GLOBAL, ONGOING CLINICAL TRIALS B

  • Clinical Trial
  • Drug Development
  • Respiratory Disease
  • World
  • Product Initiative
  • Perennial Allergic Rhinitis - Therapeutics Assessment

INS products such as Nasacort Allergy ##HRTM are recommended as the most effective drugs for the treatment of allergic rhinitis##.

  • Allergy Drug
  • Pharmaceutical
  • Respiratory Disease
  • Therapy
  • Pfizer Inc.

The company offers drugs in the areas of nephrology, oncology, immunology and allergy, central nervous system among others.

  • Immunotherapy
  • Respiratory Disease
  • United States
  • Product Initiative
  • AstraZeneca PLC

Seasonal Allergic Rhinitis Overview PIPELINE PRODUCTS FOR SEASONAL ALLERGIC RHINITIS - OVERVIEW NUMBER OF PRODUCTS UNDER DEVELOPMENT FOR SEASONAL ALLERGIC RHINITIS, H## 2016 Therapeutics Development NUMBER OF PRODUCTS UNDER DEVELOPMENT FOR SEASONAL ALLERGIC RHINITIS, H## 2016 Source: Global M

  • Allergy Drug
  • Pharmaceutical
  • Respiratory Disease
  • Therapy
  • Pfizer Inc.

The prominent features of this report are - ##.

  • Clinical Trial
  • Pharmaceutical
  • Respiratory Disease
  • Therapy
  • World

The company offers drugs in the areas of nephrology, oncology, immunology and allergy, central nervous system among others.

  • Immunotherapy
  • Research And Development
  • Respiratory Disease
  • Therapy
  • AstraZeneca PLC

Adamis and Beximco intend to introduce a number of separate drugs into the U. S. over the next years in the allergy and respiratory areas and may co-develop certain drugs.

  • Allergy Drug
  • Pharmaceutical
  • Respiratory Disease
  • Therapy
  • Pfizer Inc.